OPTOBIOTICS: NOVEL ANTIBACTERIAL PROTEINS ACTIVATED BY BLUE LIGHT

CSIC has developed a chimeric protein that, when expressed in bacteria, changes its structure upon absorption of blue light, thus generating protein aggregates (amyloids) that inhibit bacterial growth

Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement